TSX-011 Trademark

Trademark Overview

On Friday, May 19, 2017, a trademark application was filed for TSX-011 with the United States Patent and Trademark Office. The USPTO has given the TSX-011 trademark a serial number of 87456841. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 4, 2021. This trademark is owned by Tesorx Pharma, LLC. The TSX-011 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services
tsx-011

General Information

Serial Number87456841
Word MarkTSX-011
Filing DateFriday, May 19, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 4, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 3, 2017

Trademark Statements

Goods and ServicesPharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services
Pseudo MarkTESORX-0 ELEVEN

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 25, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTesorx Pharma, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 94025
Party NameTesorx Pharma, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Monday, January 4, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 4, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, November 5, 2020ASSIGNED TO EXAMINER
Thursday, April 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 1, 2020EXTENSION 5 GRANTED
Monday, March 30, 2020EXTENSION 5 FILED
Wednesday, April 1, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 30, 2020TEAS EXTENSION RECEIVED
Saturday, October 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 3, 2019EXTENSION 4 GRANTED
Thursday, October 3, 2019EXTENSION 4 FILED
Thursday, October 3, 2019TEAS EXTENSION RECEIVED
Wednesday, May 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 20, 2019EXTENSION 3 GRANTED
Monday, May 20, 2019EXTENSION 3 FILED
Monday, May 20, 2019TEAS EXTENSION RECEIVED
Wednesday, November 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 12, 2018EXTENSION 2 GRANTED
Monday, November 12, 2018EXTENSION 2 FILED
Monday, November 12, 2018TEAS EXTENSION RECEIVED
Tuesday, April 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 6, 2018EXTENSION 1 GRANTED
Friday, April 6, 2018EXTENSION 1 FILED
Friday, April 6, 2018TEAS EXTENSION RECEIVED
Tuesday, November 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 13, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, August 20, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 18, 2017ASSIGNED TO EXAMINER
Thursday, May 25, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 23, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaceutical development research services drug products